Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 12, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Metastatic Breast Cancer

Interventions

OTHER

WB-MRI

All patients will undergo a CT scan (neck/thorax/abdomen/pelvis) and a WB-MRI

Trial Locations (1)

IEO Istituto Europeo di Oncologia, Milan

All Listed Sponsors

lead

European Institute of Oncology

OTHER